Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study.
Hilde Marie EngjomRema RamakrishnanNicola VousdenKathryn BunchEdward MorrisNigel A B SimpsonChris GalePat O'BrienMaria QuigleyPeter BrocklehurstJennifer J KurinczukMarian KnightPublished in: Nature communications (2024)
There are few population-based studies of sufficient size and follow-up duration to have reliably assessed perinatal outcomes for pregnant women hospitalised with SARS-CoV-2 infection. The United Kingdom Obstetric Surveillance System (UKOSS) covers all 194 consultant-led UK maternity units and included all pregnant women admitted to hospital with an ongoing SARS-CoV-2 infection. Here we show that in this large national cohort comprising two years' active surveillance over four SARS-CoV-2 variant periods and with near complete follow-up of pregnancy outcomes for 16,627 included women, severe perinatal outcomes were more common in women with moderate to severe COVID-19, during the delta dominant period and among unvaccinated women. We provide strong evidence to recommend continuous surveillance of pregnancy outcomes in future pandemics and to continue to recommend SARS-CoV-2 vaccination in pregnancy to protect both mothers and babies.
Keyphrases
- pregnancy outcomes
- pregnant women
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- public health
- quality improvement
- early onset
- cross sectional
- emergency department
- healthcare
- type diabetes
- high intensity
- current status
- drug induced
- metabolic syndrome
- skeletal muscle
- glycemic control
- weight loss
- polycystic ovary syndrome